Three independent discounted-cash-flow-style models value Quest Diagnostics Inc. every trading day. 1 of 3 currently price DGX above its market price.
| Free Cash Flow model | $263.11 |
| Excess Profit model | $199.35 |
| Residual Earnings model | $108.36 |
| Dividend Discount model | $175.92 |
| Piotroski F-Score | 8 / 9 |
| Return on invested capital | +9.6% |
| Net debt / EBITDA | 3.4× |
| Gross margin | +33.2% |
| Revenue CAGR | +3.7% |
| Cash conversion | 1.8× |
| Dividend yield | +1.8% |
| Buyback yield | 0.0% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open DGX in StockKitty